je.st
news
Tag: gilead
Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases
2015-08-04 07:51:25| Biotech - Topix.net
This may be FDA 101 for some people, but many lay investors may not be aware of the precise details; so I am providing this brief note following the FDA itself. All new drugs and almost all drugs applying for new indications must go through a clinical research where it is tested in human subjects prior to FDA approval.
Tags: trial
errors
clinical
digest
Gilead beats Street 2Q forecasts on surge in sales, profit
2015-07-29 00:40:17| Biotech - Topix.net
Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences' second-quarter profit by 23 percent as total revenue for the biotech drugmaker jumped 26 percent and it raised its 2015 sales forecast for the second time. Gilead Sciences Inc., based in Foster City, California, said Tuesday that its net income was $4.49 billion, or $2.92 per share.
Tags: sales
street
profit
beats
Gilead Announces Executive Promotions
2015-07-28 05:55:00| Biotech - Topix.net
Gilead Sciences, Inc. today announced the promotion of William Lee, PhD to Executive Vice President, Research, and Brett Pletcher to Executive Vice President and General Counsel. Dr. Lee and Mr. Pletcher will both join Gilead's senior leadership committee.
Tags: executive
promotions
announces
gilead
Gilead Sciences to Release Second Quarter 2015 Financial Results on...
2015-07-22 22:30:04| Biotech - Topix.net
Gilead Sciences, Inc. announced today that its second quarter 2015 financial results will be released on Tuesday, July 28, at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time, Gilead's management will host a conference call to discuss the company's financial results for the second quarter 2015 and provide a general business update.
Tags: results
release
financial
sciences
Premarket Biotech Digest: Is Gilead Undervalued, Oncolytics' Reolysin, Novo Nordisk Reports Results
2015-07-13 18:14:55| Biotech - Topix.net
Gilead Sciences shares have once again seen a pullback in the last three weeks. Since June 24th, the stock is down nearly 7%, presenting another good opportunity to buy.
Tags: results
reports
novo
digest
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] next »